血液凝固因素和静脉血栓栓塞的风险:一个基于人口的研究
Anna Erhard1, Dennis Freuer1, Annette Peters2,3,4
1Epidemiology, Medical Faculty, University of Augsburg, Stenglinstr. 2, 86156, Augsburg, Germany.
European journal of medical research
|January 11, 2026
概括
在这项研究中,静脉血栓栓塞 (VTE) 的患病率为3.2%. 蛋白C,蛋白S和激活的部分血栓形成时间 (aPTT) 与静脉瘤风险相反相关.
科学领域:
- 血液学 血液学 血液学
- 流行病学 流行病学
- 临床研究 临床研究
背景情况:
- 静脉血栓栓塞 (VTE) 是一个严重的健康问题.
- 血液凝固因子和静脉瘤发病率之间的关系在一般人群中尚未得到充分证实.
研究的目的:
- 在中年和老年人群中调查VTE的患病率.
- 检查各种血液凝结因子与静脉血栓性脑脊髓炎发生之间的关联.
主要方法:
- 一项805名参与者的横截面研究 (KORA-Fit S4).
- 医生诊断的VTE通过采访来评估.
- 测量了血抗,纤维原,XVIII因子,D-二次体,蛋白C,蛋白S,aPTT和前血时间的水平.
- 多变量逻辑回归和受限制的立方线被用于分析.
主要成果:
- 自我报告的VTE患病率为3.2%.
- 在VTE和非VTE组之间没有观察到大多数凝血因子的显著差异,除了因子VIII.
- 蛋白C,蛋白S和aPTT显示与VTE有显著的非线性反向关联.
结论:
- 特定的血液凝固因子 (蛋白C,蛋白S,aPTT) 与中年和老年人中VTE患病率有关.
- 这些发现需要在前性研究中得到确认.
- 需要进一步研究凝血因子和患者特异性风险在VTE病变发生过程中的复杂相互作用.
相关概念视频
Venous Thrombosis III: Interprofessional Care
273
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
273
Venous Thrombosis I: Introduction
335
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
335
Venous Thrombosis IV: Nursing Management
191
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
191
Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.6K
Disorders of Hemostasis
2.0K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.0K
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
282
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
282


